Insmed | INSM - Revenu Net





Revenu Net Changement Date
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Cytokinetics USD -198.76M 7.27M 2026-06
DBV Technologies USD -47.6M 2.77M 2026-03
Gilead Sciences USD -10.5B 12.52B 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Novartis USD 3.16B 747M 2026-03
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06